Douglas Beck Sells 9,615 Shares of Adtalem Global Education (NYSE:CVSA) Stock

Adtalem Global Education Inc. (NYSE:CVSA) SVP Douglas Beck sold 9,615 shares of the stock in a transaction dated Friday, May 8th. The stock was sold at an average price of $127.03, for a total transaction of $1,221,393.45. Following the completion of the transaction, the senior vice president directly owned 38,159 shares of the company’s stock, valued at $4,847,337.77. This trade represents a 20.13% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Stock Up 0.2%

NYSE:CVSA opened at $128.78 on Thursday. Adtalem Global Education Inc. has a 12-month low of $86.97 and a 12-month high of $156.26. The company has a debt-to-equity ratio of 0.36, a current ratio of 0.70 and a quick ratio of 0.70. The firm has a market capitalization of $4.38 billion, a price-to-earnings ratio of 20.06, a PEG ratio of 1.07 and a beta of 0.63. The business has a 50-day simple moving average of $113.02.

Adtalem Global Education (NYSE:CVSA) last posted its quarterly earnings results on Thursday, May 7th. The company reported $1.98 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.73 by $0.25. Adtalem Global Education had a net margin of 12.26% and a return on equity of 20.19%. The firm had revenue of $487.03 million during the quarter. During the same period last year, the company earned $1.92 EPS. The business’s revenue for the quarter was up 4.5% on a year-over-year basis. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. On average, research analysts expect that Adtalem Global Education Inc. will post 8.03 EPS for the current year.

Wall Street Analyst Weigh In

CVSA has been the subject of several recent research reports. Zacks Research lowered shares of Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 25th. Weiss Ratings began coverage on shares of Adtalem Global Education in a research note on Wednesday, February 25th. They set a “hold (c+)” rating on the stock. Barrington Research reaffirmed an “outperform” rating and set a $170.00 price objective on shares of Adtalem Global Education in a research note on Friday, April 17th. Truist Financial upped their price objective on shares of Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a research note on Monday. Finally, Wall Street Zen cut shares of Adtalem Global Education from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $155.00.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.